- Investing Ideas
- /
- Swiss Potentially Undervalued Companies
Swiss Potentially Undervalued Companies
UPDATED Mar 16, 2024
Companies with a Value score of at least 3, ordered by Value score
353 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
CFTE | CHF130.00 | 5.7% | n/a | CHF988.2m | CHF153.00 | PE11.1x | n/a | 4.2% | Diversified Financials | ||
JPM | US$107.86 | 0% | 0% | US$541.4b | US$110.47 | PB1.8x | E-1.9% | 2.2% | Banks | ||
943981 | US$142.13 | 1.9% | -2.2% | US$381.2b | US$156.73 | PE28.6x | E9.7% | 3.0% | Pharmaceuticals & Biotech | ||
300 | US$63.13 | 6.2% | n/a | US$7.9b | US$79.94 | PE25.5x | E17.3% | n/a | Retail | ||
4432874 | US$224.98 | 0% | 25.8% | US$104.0b | US$229.27 | PE11.5x | E0.9% | 1.3% | Insurance | ||
0QF | US$184.33 | 0% | 40.6% | US$53.4b | US$293.47 | PE6.4x | E-15.5% | n/a | Pharmaceuticals & Biotech | ||
HUBNE | CHF79.00 | 2.1% | -10.3% | CHF1.4b | CHF97.35 | PE17.1x | E4.7% | 2.7% | Capital Goods | ||
UNC | €77.91 | 0% | n/a | €16.3b | €87.27 | PE38.8x | E24.8% | 1.5% | Pharmaceuticals & Biotech | ||
ALD | US$171.77 | 0% | n/a | US$117.3b | US$200.83 | PE23.1x | E11.4% | 2.4% | Capital Goods | ||
SQI | US$120.26 | 0% | n/a | US$39.9b | US$141.79 | PB11.5x | E-1.2% | 6.6% | Real Estate | ||
AIR | €150.84 | 0% | 0% | €117.8b | €163.97 | PE29.4x | E17.1% | 1.2% | Capital Goods | ||
HIAG | CHF72.40 | -4.7% | -9.3% | CHF731.8m | CHF100.00 | PE15.6x | E-4.6% | 4.3% | Real Estate Management and Development | ||
BAYN | €190.00 | 0% | -5.0% | €25.8b | €283.14 | PB0.8x | E43.2% | 0.4% | Pharmaceuticals & Biotech | ||
WFC | US$50.25 | 0% | 0% | US$205.2b | US$49.29 | PB1.2x | E2.2% | 2.4% | Banks | ||
SWTQ | CHF496.00 | 8.3% | -24.8% | CHF710.2m | CHF597.50 | PE25.7x | E27.2% | 3.0% | Capital Goods | ||
LLBN | CHF71.00 | 1.4% | 18.1% | CHF2.2b | CHF80.00 | PB1x | S1.5% | 3.8% | Banks | ||
AEVS | CHF16.20 | 0.6% | -10.0% | CHF1.4b | n/a | PE690.5x | n/a | 4.6% | Healthcare | ||
MS | US$42.20 | 0% | 0% | US$145.7b | US$45.32 | PE16.9x | E11.3% | 3.8% | Diversified Financials | ||
CFR | CHF145.80 | 0.5% | 9.3% | CHF85.7b | CHF144.61 | PE22.4x | E7.6% | 2.4% | Consumer Durables | ||
TEMN | CHF66.80 | 0.8% | 13.6% | CHF4.8b | CHF74.55 | PE40.4x | E14.9% | 1.8% | Software | ||
FSLR | US$190.00 | 0% | 201.8% | US$16.0b | US$287.53 | PE19x | E29.0% | n/a | Semiconductors | ||
BAC | US$28.50 | 0% | 0% | US$281.6b | US$30.49 | PB1.1x | E3.7% | 2.7% | Banks | ||
CALN | CHF28.05 | -0.7% | -34.7% | CHF234.9m | CHF32.50 | PB2x | E121.8% | 2.1% | Consumer Durables | ||
ADS | €350.70 | 0% | 0% | €36.6b | €336.73 | PE1663.8x | E41.1% | 0.3% | Consumer Durables |